2 false false false false false false false false false false true false false false false false false No description of principal activity 2024-09-01 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 15906911 2024-09-01 2025-08-31 15906911 2025-08-31 15906911 2024-08-31 15906911 bus:Director1 2024-09-01 2025-08-31 15906911 core:WithinOneYear 2025-08-31 15906911 bus:Micro-entities 2024-09-01 2025-08-31 15906911 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 15906911 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 15906911 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 15906911 bus:FullAccounts 2024-09-01 2025-08-31
COMPANY REGISTRATION NUMBER: 15906911

Marisco CDC Ltd

Unaudited financial statements

31 August 2025

Marisco CDC Ltd

Statement of financial position

31 August 2025

| 2025
| £ | £
Current assets |  | 136,448

Creditors: amounts falling due within one year |  | ( 65,258)
|  | ---------
Net current assets |  | 71,190
|  | -------
Total assets less current liabilities |  | 71,190

Accruals and deferred income |  | ( 43,968)
|  | -------
|  | 27,222
|  | -------

Capital and reserves |  | 27,222
|  | -------

Notes to the financial statements
1. Employee numbers
The average number of employees during the Period was 2 .
2. Directors' advances, credits and guarantees
During the year, the company made interest-free advances to a partnership the directors are also partners of amounting to £10,000. These were repayable on demand.
For the Period ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the Period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 1 May 2026 , and are signed on behalf of the board by:

Mr I Blakey
Director

Company registration number: 15906911
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Lovewell Blake LLP, Bankside 300 Peachman Way, Broadland Business Park, Norwich, Norfolk, NR7 0LB, United Kingdom.